RheumaGen Set to Present Breakthrough HLA Gene-Editing Research at ACR Convergence 2025 RheumaGen, Inc. will present innovative HLA gene-editing data for autoimmune diseases at ACR Convergence 2025, highlighting its potential impact.

RheumaGen Set to Present Breakthrough HLA Gene-Editing Research at ACR Convergence 2025 #USA #Aurora #RheumaGen #rheumatoid_arthritis #HLA_Gene_Editing